Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece.

[1]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[2]  A. Tsakris,et al.  Imported Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Clones in a Greek Hospital: Impact of Infection Control Measures for Restraining Their Dissemination , 2012, Journal of Clinical Microbiology.

[3]  Y. Carmeli,et al.  Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. Campos,et al.  Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  G L French,et al.  The continuing crisis in antibiotic resistance. , 2010, International journal of antimicrobial agents.

[6]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[7]  Y. Carmeli,et al.  Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  A. Armaganidis,et al.  An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  H. Maltezou,et al.  KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  H. Maltezou.  Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? , 2009, International journal of antimicrobial agents.

[11]  V. Raftopoulos,et al.  Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). , 2009, The Journal of infection.

[12]  C. Bamia,et al.  Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections , 2009, Antimicrobial Agents and Chemotherapy.

[13]  S. Pournaras,et al.  Evaluation of Boronic Acid Disk Tests for Differentiating KPC-Possessing Klebsiella pneumoniae Isolates in the Clinical Laboratory , 2008, Journal of Clinical Microbiology.

[14]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[15]  A. Vatopoulos.  High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  D. Landman,et al.  Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. , 2007, The Journal of antimicrobial chemotherapy.

[17]  D. Landman,et al.  Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. , 2005, The Journal of antimicrobial chemotherapy.

[18]  M. Maniati,et al.  Novel Variant (blaVIM-4) of the Metallo-β-Lactamase Gene blaVIM-1 in a Clinical Strain of Pseudomonas aeruginosa , 2002, Antimicrobial Agents and Chemotherapy.

[19]  R. Ambler,et al.  The structure of beta-lactamases. , 1980, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[20]  U. Pennsylvania,et al.  Clinical and Laboratory Standards Institute , 2019, Springer Reference Medizin.

[21]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .